6PN-11963-99390

4 vaccinations 14 coded responses 37 check-ins 14 free-text entries 3 call cases

Sex: Female
Age at first dose: 56-60
ZIP prefix: 991 / WA
Registered: 2021-01-24

Relationship: Self
Race: White
Ethnicity: Not Hispanic or Latino

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-01-24
Registered in v-safe
2021-01-24
Dose 1 — Pfizer-BioNTech
2021-01-24
Health check-in — day 0, dose 1
Feeling: Good · None

Adult check-in
2021-01-25
Survey response — days 1–6 daily, dose 1
MedDRA: Oropharyngeal pain — Feeling: Fair · Site: Pain

Free text: Rasoy, sore throat

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-26
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · Nausea

Adult check-in
2021-01-27
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · Nausea

Adult check-in
2021-01-28
Survey response — days 1–6 daily, dose 1
MedDRA: Dysphonia, Oropharyngeal pain — Feeling: Fair · Site: Pain · Nausea

Free text: Raspy, sore throat

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-29
Survey response — days 1–6 daily, dose 1
MedDRA: Oropharyngeal discomfort, Oropharyngeal pain — Feeling: Fair · Site: Pain · Nausea

Free text: Raspy, sire throat

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-30
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · Nausea

Adult check-in
2021-01-31
Survey response — day 7, dose 1
MedDRA: Dysphonia, Nausea, Oropharyngeal pain — Feeling: Good · Site: Pain

Free text: Raspy, sore throat gone day 6. Nausea gone day 7

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-07
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-02-14
Dose 2 — Pfizer-BioNTech
2021-02-14
Health check-in — day 0, dose 2
Feeling: Good · Site: Pain · Nausea

Adult check-in
2021-02-15
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Muscle or body aches, Nausea

Adult check-in
2021-02-16
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tiredness, Nausea

Adult check-in
2021-02-17
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Headache

Adult check-in
2021-02-18
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-02-19
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness, Nausea

Adult check-in
2021-02-20
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-02-21
Survey response — day 7, dose 2
MedDRA: Pain — Feeling: Fair · Site: Pain · Muscle or body aches

Free text: Sore, radpy throat again; similar to effects of 1st vaccine. I'm on immunosuppressive therapy.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-28
Survey response — day 14, dose 2
MedDRA: Oropharyngeal pain — Feeling: Good

Free text: Raspy sore throat still, but seems less today.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-07
Survey response — day 21, dose 2
MedDRA: Oropharyngeal pain — Feeling: Fair

Free text: Sore, raspy throat

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-14
Survey response — day 28, dose 2
MedDRA: Multiple sclerosis, Pre-existing disease — Feeling: Good

Free text: Worsening MS

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-21
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-03-28
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-05-16
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-08-15
Health check-in — 6 months, dose 2
Feeling: Fair

Adult check-in
2021-09-19
Dose 3 — Pfizer-BioNTech
2022-02-14
Survey response — 12 months, dose 2
MedDRA: Gait disturbance, Multiple sclerosis, Pre-existing disease — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: MS exacerbation, with right leg dragging

MedDRA releases: 2024-11 · check-in free text available
2022-02-14
Report sent to call center — 12 months, dose 2
Get care from a doctor or other healthcare professional

Telehealth, virtual health, or email health consultation · 1 call case(s)
2022-02-16
Call successful
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
2022-04-15
Dose 4 — Pfizer-BioNTech
2022-04-19
Health check-in — days 1–6 daily, dose 4
Feeling: Fair · Site: Swelling · Fever · Headache, Fatigue or tiredness

Adult check-in
2022-04-20
Health check-in — days 1–6 daily, dose 4
Feeling: Fair · Site: Swelling · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness

Adult check-in
2022-04-21
Health check-in — days 1–6 daily, dose 4
Feeling: Fair · Site: Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness

Adult check-in
2022-04-22
Health check-in — day 7, dose 4
Feeling: Poor · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2022-04-29
Health check-in — day 14, dose 4
Feeling: Fair

Adult check-in
2022-05-06
Survey response — day 21, dose 4
MedDRA: Multiple sclerosis, Pre-existing disease — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: MS exacerbation

MedDRA releases: 2024-11 · check-in free text available
2022-05-13
Survey response — day 28, dose 4
MedDRA: Exertional headache, Headache — Feeling: Fair · Be unable to do your normal daily activities

Free text: Headache 24/7, with a severe headache rush when changing from lying down to standing

MedDRA releases: 2024-11 · check-in free text available
2022-05-20
Survey response — day 35, dose 4
MedDRA: Migraine, Multiple sclerosis, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activities

Free text: MS exacerbation and severe migrainous headaches

MedDRA releases: 2024-11 · check-in free text available
2022-05-27
Health check-in — day 42, dose 4
Feeling: Fair

Adult check-in
2022-07-15
Survey response — 3 months, dose 4
MedDRA: Multiple sclerosis, Pre-existing disease — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: MS related exacerbation

MedDRA releases: 2024-11 · check-in free text available
2022-07-15
Report sent to call center — 3 months, dose 4
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-07-18
Call 1 — Left Voicemail
2022-07-18
Call 1 — Left Voicemail
2022-10-14
Survey response — 6 months, dose 4
MedDRA: Multiple sclerosis, Pre-existing disease — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Ms exacerbation

MedDRA releases: 2024-11 · check-in free text available
2022-10-14
Report sent to call center — 6 months, dose 4
Get care from a doctor or other healthcare professional

Telehealth, virtual health, or email health consultation · 1 call case(s)
2022-10-17
Call 2 — Left Voicemail
2022-10-17
Call 1 — Left Voicemail
2023-04-17
Health check-in — 12 months, dose 4
Feeling: Fair

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-01-24	Pfizer-BioNTech
2	2021-02-14	Pfizer-BioNTech
3	2021-09-19	Pfizer-BioNTech	No
4	2022-04-15	Pfizer-BioNTech	No

Call center

3 call center cases

1 successful · 2 unsuccessful

1 wait over 3 months for a first call

See the call center timeline

Free text

Release 2 — days 1–6 daily, dose 1

2021-01-25

Systemic reaction (other): Rasoy, sore throat

2021-01-28

Systemic reaction (other): Raspy, sore throat

Release 3 — days 1–6 daily, dose 1

2021-01-29

Systemic reaction (other): Raspy, sire throat

Release 3 — day 7, dose 1

2021-01-31

Systemic reaction (other): Raspy, sore throat gone day 6. Nausea gone day 7

Release 4 — day 7, dose 2

2021-02-21

Systemic reaction (other): Sore, radpy throat again; similar to effects of 1st vaccine. I'm on immunosuppressive therapy.

Release 4 — day 14, dose 2

2021-02-28

Symptoms: Raspy sore throat still, but seems less today.

Release 5 — day 21, dose 2

2021-03-07

Symptoms: Sore, raspy throat

Release 5 — day 28, dose 2

2021-03-14

Symptoms: Worsening MS

Release 11 — 12 months, dose 2

2022-02-14

Symptoms: MS exacerbation, with right leg dragging

Release 11 — day 21, dose 4

2022-05-06

Symptoms: MS exacerbation

Release 11 — day 28, dose 4

2022-05-13

Symptoms: Headache 24/7, with a severe headache rush when changing from lying down to standing

Release 11 — day 35, dose 4

2022-05-20

Symptoms: MS exacerbation and severe migrainous headaches

Release 12 — 3 months, dose 4

2022-07-15

Symptoms: MS related exacerbation

Release 12 — 6 months, dose 4

2022-10-14

Symptoms: Ms exacerbation

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Exertional headache	·	·	✓
SD	Gait disturbance	·	·	✓
SD	Headache	·	·	✓
SD	Migraine	·	·	✓
SD	Multiple sclerosis	✓	✓	✓
SD	Oropharyngeal pain	✓	✓	✓
SD	Pre-existing disease	✓	✓	✓
SRO	Dysphonia	✓	✓	✓
SRO	Nausea	✓	✓	✓
SRO	Oropharyngeal discomfort	✓	✓	✓
SRO	Oropharyngeal pain	✓	✓	✓
SRO	Pain	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release